New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 3, 2014
09:06 EDTBAYRYBayer says CEO Dekkers to step down at end of 2016
Bayer announced that the contract of Dr. Marijn Dekkers will be extended by just two years on expiration of the initial five-year period. Dekkers cited family reasons for extending his contract only until the end of 2016. The company's board has appointed Werner Baumann, currently CFO, as Chief Strategy and Portfolio Officer effective October 1, 2014. Baumannís existing contract runs until December 31, 2017. Also effective October 1, Johannes Dietsch, currently Senior Bayer Representative and CFO for Greater China based in Shanghai, will assume the position of CFO. He will be appointed to the Board of Management of Bayer effective September 1, 2014.
News For BAYRY From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
June 26, 2015
05:25 EDTBAYRYRegeneron reports approval of Eylea by Japan
Subscribe for More Information
June 25, 2015
14:01 EDTBAYRYBayer initiated with a Buy at HSBC
Subscribe for More Information
08:00 EDTBAYRYBayer to hold a meeting
Subscribe for More Information
June 23, 2015
10:31 EDTBAYRYMonsanto says Bayer crop chemicals unit an option, Bloomberg reports
Subscribe for More Information
June 16, 2015
06:23 EDTBAYRYAcura enters into agreement with Pharma Bayer for IMPEDE
Acura Pharmaceuticals (ACUR) announced that Acura has entered into a License and Development Agreement with Bayer Healthcare (BAYRY) to provide an exclusive worldwide license to Acura's IMPEDE technology for use in an undisclosed methamphetamine resistant pseudoephedrine containing product and to jointly develop such product utilizing the IMPEDE technology for the U.S. market. Bayer has the right to negotiate for a worldwide license to the IMPEDE technology for additional products.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use